TY  - GEN 
AU  - Justicia Lirio, Pedro
AU  - Tristán-Manzano, María
AU  - Maldonado Pérez, Noelia
AU  - Barbero-Jiménez, Carmen
AU  - Cortijo Gutiérrez, Marina
AU  - Pavlovic, Kristina
AU  - Molina-Estévez, Francisco Javier
AU  - Muñoz, Pilar
AU  - Hinckley-Boned, Ana
AU  - Rodriguez-Madoz, Juan R
AU  - Prósper, Felipe
AU  - Griñan-Lison, Carmen
AU  - Navarro-Marchal, Saúl A
AU  - Muñoz-Ballester, Julia
AU  - Gonzalez-Sierra, Pedro A
AU  - Herrera, Concha
AU  - Marchal Corrales, Juan Antonio
AU  - Martín, Francisco
PY  - 2024
UR  - https://hdl.handle.net/10481/99255
AB  - Although chimeric antigen receptor (CAR) T cell therapy has
revolutionized type B cancer treatment, efficacy remains limited
in various lymphomas and solid tumors. Reinforcing conventionalCAR-
T cells to release cytokines can improve their...
TI  - First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B-cell lymphomas
DO  - doi.org/10.1016/j.omtn.2024.102308
ER  -